Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The heme detoxification process is a vital metabolic pathway in Plasmodium parasites, particularly Plasmodium falciparum, occurring within the acidic digestive vacuole during the intraerythrocytic stage of infection (Coronado et al., 2014, NIH). As the parasite digests host hemoglobin to obtain essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its capacity to generate reactive oxygen species and disrupt cellular membranes (Hempelmann, 2007, PubMed). To mitigate this toxicity, the parasite converts free heme into an inert, insoluble crystalline polymer known as hemozoin, or malaria pigment. This biocrystallization is facilitated by the Heme Detoxification Protein (HDP) and occurs within the lipid environment of the vacuole (Jani et al., 2008, PLoS Pathogens). This pathway is the primary target for several classes of antimalarial drugs, including 4-aminoquinolines like chloroquine and quinoline alcohols like quinine. These drugs interfere with the formation of hemozoin, leading to the accumulation of toxic heme and subsequent parasite death (StatPearls, 2023). Despite the rise of drug resistance mediated by transporters like PfCRT, this process remains a critical focus for antimalarial drug discovery.
Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic ferriprotoporphyrin IX (heme) which causes oxidative damage and parasite lysis (StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme detoxification process (HDP).